Madrigal (Nasdaq: MDGL) is a biopharmaceutical company pursuing novel therapeutics for nonalcoholic steatohepatitis (NASH), also known as metabolic dysfunction associated steatohepatitis (MASH). Our first therapy was granted accelerated approval by the U.S. Food and Drug Administration (FDA) for the...
Use this information to figure out if this company is an ideal customer for you.
2675131789
45 Hartwell Avenue
Lexington, 02421
11 - 50 Employees
$50M - $100M
linkedin.com/company/madrigal-pharmaceuticals-inc-
Madrigal Pharmaceuticals's CEO is Rebecca Taub
Madrigal Pharmaceuticals's CMO is Rebecca Taub
Madrigal Pharmaceuticals's CFO is Mardi Dier
Madrigal Pharmaceuticals's HQ is located at 45 Hartwell Avenue, Lexington
Madrigal Pharmaceuticals's phone number is 2675131789
Madrigal Pharmaceuticals's official website is madrigalpharma.com
Madrigal Pharmaceuticals's revenue is $50M - $100M
Madrigal Pharmaceuticals has 11 - 50 employees
Madrigal Pharmaceuticals is in the industry of: Pharmaceuticals
